Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced preliminary neutralizing antibody data against the Omicron variant following the Company ...

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced initial data from its Phase 2 study showing that a single 50 µg dose of mRNA-1273 or ...

Moderna said Monday that a booster dose of its covid-19 vaccine should offer protection against the rapidly spreading omicron variant. Moderna said lab tests showed the half-dose booster shot ...

New data from Moderna offer hope that booster shots against Covid-19 could become at least somewhat more effective than they already are.

However, these data showing that the currently authorized Moderna COVID-19 booster can boost neutralizing antibody levels 37-fold higher than pre-boost levels are reassuring,” said Stéphane ...

Moderna said lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to fight omicron.

Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant. The Cambridge-based biotech company said lab tests showed the ...

Moderna said lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies.

Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.

News Moderna: Initial booster data shows good results on omicron Lab tests showed the half-dose booster shot increased by 37 times the level of so-called neutralizing antibodies able to fight omicron.

Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.